Qrono Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 8

Qrono General Information

Description

Operator of patentable nanomedicines and drug development company intended to reprogram antigen-presenting cells in cancer and other diseases. The company platform aims for transformation through long-acting drug formulation specificity that produces drugs with new efficacies against validated targets, providing healthcare professionals with cost-effective, low-toxicity treatment options for activating anti-cancer immune cells.

Contact Information

Website
www.qrono.com
Formerly Known As
ChroKnow
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2403 Sidney Street
  • Suite 225
  • Pittsburgh, PA 15203
  • United States
+1 (412)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 2403 Sidney Street
  • Suite 225
  • Pittsburgh, PA 15203
  • United States
+1 (412)

Qrono Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qrono Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator Completed Pre-Clinical Trials
8. Grant 10-Jan-2022 Completed Pre-Clinical Trials
7. Grant 15-Jun-2021 Completed Pre-Clinical Trials
6. Later Stage VC 05-May-2017 Completed Pre-Clinical Trials
5. Grant 01-Jan-2016 Completed Pre-Clinical Trials
4. Grant 09-Jan-2013 Completed Startup
3. Angel (individual) 30-Nov-2012 Completed Startup
2. Accelerator/Incubator 17-Jul-2012 $50K $50K Completed Startup
1. University Spin-Out 01-Jan-2010 Completed Startup
To view Qrono’s complete valuation and funding history, request access »

Qrono Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of patentable nanomedicines and drug development company intended to reprogram antigen-presenting cells in canc
Drug Discovery
Pittsburgh, PA
5 As of 2024

Berlin, Germany
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Qrono Competitors (2)

One of Qrono’s 2 competitors is Mologen, a Formerly Angel backed company based in Berlin, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mologen Formerly Angel backed Berlin, Germany
BeyondSpring Formerly VC-backed New York, NY
You’re viewing 2 of 2 competitors. Get the full list »

Qrono Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Qrono Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3373907-A1 Sustained release pharmaceutical compositions and methods of use Inactive 11-Nov-2015
US-20200276168-A1 Sustained release pharmaceutical compositions and methods of use Inactive 11-Nov-2015
US-20170128424-A1 Sustained release pharmaceutical compositions and methods of use Inactive 11-Nov-2015
US-20190117629-A1 Sustained release pharmaceutical compositions and methods of use Inactive 11-Nov-2015
EP-3373907-A4 Sustained release pharmaceutical compositions and methods of use Inactive 11-Nov-2015 A61K31/427
To view Qrono’s complete patent history, request access »

Qrono Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qrono Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
National Institute Of Allergy and Infectious Diseases Government
Pittsburgh Life Sciences Greenhouse Venture Capital Minority
U.S. Food and Drug Administration Government
National Cancer Institute Government
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Qrono FAQs

  • When was Qrono founded?

    Qrono was founded in 2010.

  • Where is Qrono headquartered?

    Qrono is headquartered in Pittsburgh, PA.

  • What is the size of Qrono?

    Qrono has 5 total employees.

  • What industry is Qrono in?

    Qrono’s primary industry is Drug Discovery.

  • Is Qrono a private or public company?

    Qrono is a Private company.

  • What is Qrono’s current revenue?

    The current revenue for Qrono is .

  • How much funding has Qrono raised over time?

    Qrono has raised $300K.

  • Who are Qrono’s investors?

    National Institutes of Health, National Institute Of Allergy and Infectious Diseases, Pittsburgh Life Sciences Greenhouse, U.S. Food and Drug Administration, and National Cancer Institute are 5 of 8 investors who have invested in Qrono.

  • Who are Qrono’s competitors?

    Mologen and BeyondSpring are competitors of Qrono.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »